APR PATENDED TECHNOLOGICAL INNOVATION:
A PHARMACEUTICAL TECHNOLOGY APPLIED TO MEDICAL FOOD.
FOR A REAL CHANGE IN AMINO ACID FORMULATIONS FOR PKU PEOPLE.
APR 1301-01 is an advanced formulation of Amino Acids, enriched with vitamins and minerals, with the potential of contributing to better control of Phenylalanine metabolism in PKU patients.
Thanks to APR healthcare company's innovative Physiomimic™ patented technology, it allows to obtain a revolutionary formulation in coated micro granules engineered to permit a prolonged Amino Acid release.
A prolonged release sustains a physiological Amino Acid absorption.
The applied innovative Physiomimic™ technology results in full masking of the unpleasant taste and odor of free Amino Acid formulations and, as a consequence, may eliminate the typical unwanted aftertaste effect.
Each micro granule, 100% Phenylalanine-free, contains all the needed Amino Acids and functional additives.
It is able to:
- - Provide a slower release of Amino Acids compared to a non-engineered free Amino Acid mix, with the aim of supporting a physiological AA absorption.
- - Mask bad odor and upsetting taste typical of free Amino Acid mixes, blanking out the inconvenient aftertaste effect, for a tangible advancement of patient acceptance.